Over the last 12 months, Fractyl Health insiders reported 5 buys totaling $127K and no sales across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Royan AjayD | ▲ Buy | 23,000 | $0.85 | $20K | +128.5% | — |
| Jun 10, 2026 | BRADLEY WILLIAMD | ▲ Buy | 68,493 | $0.73 | $50K | +424.7% | — |
| Jun 10, 2026 | Sheffield IanD | ▲ Buy | 35,000 | $0.73 | $26K | — | — |
| Jun 10, 2026 | Rajagopalan HarithChief Executive Officer · O·D | ▲ Buy | 25,000 | $0.73 | $18K | +4.8% | — |
| Jun 8, 2026 | Smith Weber LaraChief Financial Officer · O | ▲ Buy | 20,000 | $0.69 | $14K | — | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $GUTS feed.